Lunai Bioworks (LNAI) Current Leases (2019 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Current Leases of $288390.0 in Q1 2026, up 4.88% quarter-over-quarter from $274983.0 in Q4 2025, and down 47.34% on a YoY basis from $547683.0 in Q1 2025.
Lunai Bioworks (LNAI) Current Leases (2019 - 2026) Analysis & Trends
Lunai Bioworks' Current Leases history runs 8 years deep, the most recent figure standing at $288390.0 for Q1 2026.
- In Q1 2026, Current Leases fell 47.34% year-over-year to $288390.0; the TTM figure through Mar 2026 stood at $288390.0 (down 47.34% YoY), while the FY2025 annual figure was $313047.0, down 36.57% from the prior year.
- Current Leases was $288390.0 for Q1 2026 at Lunai Bioworks, up from $274983.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $562287.0 in Q4 2024 to a low of $193422.0 in Q2 2023.
- Historically, Current Leases has averaged $324130.1 across 5 years, with a median of $277775.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Current Leases jumped 157.83% in 2024, then slumped 51.1% in 2025.
- A 5-year view of Current Leases shows it stood at $202370.0 in 2022, then advanced by 7.77% to $218085.0 in 2023, then surged by 157.83% to $562287.0 in 2024, then plunged by 51.1% to $274983.0 in 2025, then gained by 4.88% to $288390.0 in 2026.
- The last three Current Leases figures came in at $288390.0 (Q1 2026), $274983.0 (Q4 2025), and $277775.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | 288,390.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288,390.00 |
| Dec 31, 2025 | 274,983.00 |
| Sep 30, 2025 | 277,775.00 |
| Jun 30, 2025 | 313,047.00 |
| Mar 31, 2025 | 547,683.00 |
| Dec 31, 2024 | 562,287.00 |
| Sep 30, 2024 | 504,254.00 |
| Jun 30, 2024 | 493,553.00 |
| Mar 31, 2024 | 483,226.00 |
| Dec 31, 2023 | 218,085.00 |
| Sep 30, 2023 | 214,061.00 |
| Jun 30, 2023 | 193,422.00 |
| Mar 31, 2023 | 206,222.00 |
| Dec 31, 2022 | 202,370.00 |
| Sep 30, 2022 | 198,557.00 |
| Jun 30, 2022 | 253,636.00 |
| Mar 31, 2022 | 278,661.00 |
| Dec 31, 2021 | 303,488.00 |
| Sep 30, 2021 | 297,896.00 |
| Jun 30, 2021 | 292,409.00 |